De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome - PubMed (original) (raw)
De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome
T Matsuura et al. Nat Genet. 1997 Jan.
Abstract
Angelman syndrome (AS) is associated with maternal deletions of human chromosome 15q11-q13 and with paternal uniparental disomy for this region indicating that deficiency of an imprinted, maternally expressed gene within the critical interval is the likely cause of the syndrome. Although the gene for E6-AP ubiquitin-protein ligase (UBE3A) was mapped to the critical region for AS, evidence of expression from both parental alleles initially suggested that it was an unlikely candidate gene for this disorder. Because attempts to identify any novel maternally expressed transcripts were unsuccessful and because the UBE3A gene remained within a narrowed AS critical region, we searched for mutations in UBE3A in 11 AS patients without known molecular defects (large deletion, uniparental disomy, or imprinting mutation). This analysis tested the possibility that deficiency of an undefined, maternally expressed transcript or isoform of the UBE3A gene could cause AS. Four mutations were identified including a de novo frameshift mutation and a de novo nonsense mutation in exon 3 and two missense mutations of less certain significance. The de novo truncating mutations indicate that UBE3A is the AS gene and suggest the possibility of a maternally expressed gene product in addition to the biallelically expressed transcript. Intragenic mutation of UBE3A in AS is the first example of a genetic disorder of the ubiquitin-dependent proteolytic pathway in mammals. It may represent an example of a human genetic disorder associated with a locus producing functionally distinct imprinted and biallelically expressed gene products.
Similar articles
- The E6-Ap ubiquitin-protein ligase (UBE3A) gene is localized within a narrowed Angelman syndrome critical region.
Sutcliffe JS, Jiang YH, Galijaard RJ, Matsuura T, Fang P, Kubota T, Christian SL, Bressler J, Cattanach B, Ledbetter DH, Beaudet AL. Sutcliffe JS, et al. Genome Res. 1997 Apr;7(4):368-77. doi: 10.1101/gr.7.4.368. Genome Res. 1997. PMID: 9110176 Free PMC article. - UBE3A/E6-AP mutations cause Angelman syndrome.
Kishino T, Lalande M, Wagstaff J. Kishino T, et al. Nat Genet. 1997 Jan;15(1):70-3. doi: 10.1038/ng0197-70. Nat Genet. 1997. PMID: 8988171 - The spectrum of mutations in UBE3A causing Angelman syndrome.
Fang P, Lev-Lehman E, Tsai TF, Matsuura T, Benton CS, Sutcliffe JS, Christian SL, Kubota T, Halley DJ, Meijers-Heijboer H, Langlois S, Graham JM Jr, Beuten J, Willems PJ, Ledbetter DH, Beaudet AL. Fang P, et al. Hum Mol Genet. 1999 Jan;8(1):129-35. doi: 10.1093/hmg/8.1.129. Hum Mol Genet. 1999. PMID: 9887341 - Novel intragenic deletions within the UBE3A gene in two unrelated patients with Angelman syndrome: case report and review of the literature.
Aguilera C, Viñas-Jornet M, Baena N, Gabau E, Fernández C, Capdevila N, Cirkovic S, Sarajlija A, Miskovic M, Radivojevic D, Ruiz A, Guitart M. Aguilera C, et al. BMC Med Genet. 2017 Nov 21;18(1):137. doi: 10.1186/s12881-017-0500-x. BMC Med Genet. 2017. PMID: 29162042 Free PMC article. Review. - Angelman syndrome: how many genes to remain silent?
Rougeulle C, Lalande M. Rougeulle C, et al. Neurogenetics. 1998 Aug;1(4):229-37. doi: 10.1007/s100480050034. Neurogenetics. 1998. PMID: 10732796 Review.
Cited by
- Genotype-phenotype correlation over time in Angelman syndrome: Researching 134 patients.
Fujimoto M, Nakamura Y, Hosoki K, Iwaki T, Sato E, Ieda D, Hori I, Negishi Y, Hattori A, Shiraishi H, Saitoh S. Fujimoto M, et al. HGG Adv. 2024 Aug 22;5(4):100342. doi: 10.1016/j.xhgg.2024.100342. Online ahead of print. HGG Adv. 2024. PMID: 39169619 Free PMC article. - Integration of CTCF loops, methylome, and transcriptome in differentiating LUHMES as a model for imprinting dynamics of the 15q11-q13 locus in human neurons.
Gutierrez Fugón OJ, Sharifi O, Heath N, Soto DC, Gomez JA, Yasui DH, Mendiola AJP, O'Geen H, Beitnere U, Tomkova M, Haghani V, Dillon G, Segal DJ, LaSalle JM. Gutierrez Fugón OJ, et al. Hum Mol Genet. 2024 Sep 19;33(19):1711-1725. doi: 10.1093/hmg/ddae111. Hum Mol Genet. 2024. PMID: 39045627 Free PMC article. - Ube3a unsilencer for the potential treatment of Angelman syndrome.
Vihma H, Li K, Welton-Arndt A, Smith AL, Bettadapur KR, Gilmore RB, Gao E, Cotney JL, Huang HC, Collins JL, Chamberlain SJ, Lee HM, Aubé J, Philpot BD. Vihma H, et al. Nat Commun. 2024 Jul 8;15(1):5558. doi: 10.1038/s41467-024-49788-8. Nat Commun. 2024. PMID: 38977672 Free PMC article. - Ubiquitin system mutations in neurological diseases.
Zenge C, Ordureau A. Zenge C, et al. Trends Biochem Sci. 2024 Oct;49(10):875-887. doi: 10.1016/j.tibs.2024.06.011. Epub 2024 Jul 6. Trends Biochem Sci. 2024. PMID: 38972780 Review. - Expanding deep phenotypic spectrum associated with atypical pathogenic structural variations overlapping 15q11-q13 imprinting region.
Mim RA, Soorajkumar A, Kosaji N, Rahman MM, Sarker S, Karuvantevida N, Eshaque TB, Rahaman MA, Islam A, Chowdhury MSJ, Shams N, Uddin KMF, Akter H, Uddin M. Mim RA, et al. Brain Behav. 2024 Apr;14(4):e3437. doi: 10.1002/brb3.3437. Brain Behav. 2024. PMID: 38616334 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials